Insider · CIK 0001250409

Bird Jeffrey W

CIK 0001250409 Name as filed on the most recent filing

Filed as Bird Jeffrey W (71)

154 transaction lines · from 71 filings · filed 2004-12-17 to 2019-07-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

144 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2012-03-02 P, Open-market purchase Horizon Pharma, Inc.HZNP 17,950, acquired Open Form 4 filing 0001225208-12-006943
2012-02-13 P, Open-market purchase Cardica IncCRDC 532,714, acquired Open Form 4 filing 0001225208-12-004095
2012-02-13 P, Open-market purchase Cardica IncCRDC 21,273, acquired Open Form 4 filing 0001225208-12-004087
2011-08-02 P, Open-market purchase Horizon Pharma, Inc.HZNP 2 lines 1,290,015, acquired Open Form 4 filing 0001225208-11-019292
2011-03-11 P, Open-market purchase Threshold Pharmaceuticals IncTHLD 44,020, acquired Open Form 4 filing 0001225208-11-009724
2011-03-11 P, Open-market purchase Threshold Pharmaceuticals IncTHLD 1,451,035, acquired Open Form 4 filing 0001223203-11-000007
2009-10-16 P, Open-market purchase Corcept Therapeutics IncCORT 29,816, acquired Open Form 4 filing 0001225208-09-020712
2009-10-16 P, Open-market purchase Corcept Therapeutics IncCORT 1,256,572, acquired Open Form 4 filing 0001225208-09-020722
2009-10-05 P, Open-market purchase Threshold Pharmaceuticals IncTHLD 66,271, acquired Open Form 4 filing 0001225208-09-020325
2009-10-05 P, Open-market purchase Threshold Pharmaceuticals IncTHLD 2,184,532, acquired Open Form 4 filing 0001225208-09-020338
2009-02-06 P, Open-market purchase Corcept Therapeutics IncCORT 2 lines 356,620, acquired Open Form 4 filing 0001250409-09-000002
2008-06-02 P, Open-market purchase Eloyalty CorpELOY 2 lines 91,836, acquired Open Form 4 filing 0001250409-08-000019
2008-05-30 P, Open-market purchase Eloyalty CorpELOY 2 lines 127,595, acquired Open Form 4 filing 0001250409-08-000018
2008-05-29 P, Open-market purchase Eloyalty CorpELOY 2 lines 39,079, acquired Open Form 4 filing 0001250409-08-000018
2008-05-28 P, Open-market purchase Eloyalty CorpELOY 2 lines 119,327, acquired Open Form 4 filing 0001250409-08-000017
2008-05-27 P, Open-market purchase Eloyalty CorpELOY 2 lines 138,587, acquired Open Form 4 filing 0001250409-08-000017
2008-05-23 P, Open-market purchase Eloyalty CorpELOY 2 lines 301,904, acquired Open Form 4 filing 0001250409-08-000016
2008-05-22 P, Open-market purchase Eloyalty CorpELOY 9,840, acquired Open Form 4 filing 0001250409-08-000016
2008-05-21 P, Open-market purchase Eloyalty CorpELOY 2 lines 155,480, acquired Open Form 4 filing 0001250409-08-000015
2008-05-20 P, Open-market purchase Eloyalty CorpELOY 3,315, acquired Open Form 4 filing 0001250409-08-000015
2008-05-19 P, Open-market purchase Eloyalty CorpELOY 2 lines 101,964, acquired Open Form 4 filing 0001250409-08-000014
2008-05-16 P, Open-market purchase Eloyalty CorpELOY 2 lines 102,196, acquired Open Form 4 filing 0001250409-08-000014
2008-05-15 P, Open-market purchase Eloyalty CorpELOY 2 lines 39,122, acquired Open Form 4 filing 0001250409-08-000013
2008-05-14 P, Open-market purchase Eloyalty CorpELOY 2 lines 61,094, acquired Open Form 4 filing 0001250409-08-000013
2008-05-13 P, Open-market purchase Eloyalty CorpELOY 2 lines 50,447, acquired Open Form 4 filing 0001250409-08-000012
2008-05-12 P, Open-market purchase Eloyalty CorpELOY 2 lines 185,783, acquired Open Form 4 filing 0001250409-08-000012
2008-03-25 P, Open-market purchase Corcept Therapeutics IncCORT 2 lines 1,962,922, acquired Open Form 4 filing 0001250409-08-000011
2008-03-14 P, Open-market purchase Eloyalty CorpELOY 2 lines 48,377, acquired Open Form 4 filing 0001250409-08-000010
2008-03-13 P, Open-market purchase Eloyalty CorpELOY 2 lines 110,238, acquired Open Form 4 filing 0001250409-08-000009
2008-03-12 P, Open-market purchase Eloyalty CorpELOY 2 lines 64,848, acquired Open Form 4 filing 0001250409-08-000009
2008-03-11 P, Open-market purchase Eloyalty CorpELOY 16,361, acquired Open Form 4 filing 0001250409-08-000008

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 133
  • Open-market sale 11
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BIRD JEFFREY W, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001250409

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.